###begin article-title 0
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF</italic>
Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 29 51 29 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 324 331 324 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 375 389 375 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 29 50 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 184 192 <span type="species:ncbi:9606">patients</span>
###xml 375 388 <span type="species:ncbi:5833">P. falciparum</span>
Susceptibility/resistance to Plasmodium falciparum malaria has been correlated with polymorphisms in more than 30 human genes with most association analyses having been carried out on patients from Africa and south-east Asia. The aim of this study was to examine the possible contribution of genetic variants in the TNF and FCGR2A genes in determining severity/resistance to P. falciparum malaria in Indian subjects.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 135 142 135 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
Allelic frequency distribution in populations across India was first determined by typing genetic variants of the TNF enhancer and the FCGR2A G/A SNP in 1871 individuals from 55 populations. Genotyping was carried out by DNA sequencing, single base extension (SNaPshot), and DNA mass array (Sequenom). Plasma TNF was determined by ELISA. Comparison of datasets was carried out by Kruskal-Wallis and Mann-Whitney tests. Haplotypes and LD plots were generated by PHASE and Haploview, respectively. Odds ratio (OR) for risk assessment was calculated using EpiInfotrade mark version 3.4.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 163 170 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 233 247 233 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 1099 1113 1095 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 233 246 <span type="species:ncbi:5833">P. falciparum</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
###xml 654 662 <span type="species:ncbi:9606">patients</span>
###xml 1099 1112 <span type="species:ncbi:5833">P. falciparum</span>
A novel single nucleotide polymorphism (SNP) at position -76 was identified in the TNF enhancer along with other reported variants. Five TNF enhancer SNPs and the FCGR2A R131H (G/A) SNP were analyzed for association with severity of P. falciparum malaria in a malaria-endemic and a non-endemic region of India in a case-control study with ethnically-matched controls enrolled from both regions. TNF -1031C and -863A alleles as well as homozygotes for the TNF enhancer haplotype CACGG (-1031T>C, -863C>A, -857C>T, -308G>A, -238G>A) correlated with enhanced plasma TNF levels in both patients and controls. Significantly higher TNF levels were observed in patients with severe malaria. Minor alleles of -1031 and -863 SNPs were associated with increased susceptibility to severe malaria. The high-affinity IgG2 binding FcgammaRIIa AA (131H) genotype was significantly associated with protection from disease manifestation, with stronger association observed in the malaria non-endemic region. These results represent the first genetic analysis of the two immune regulatory molecules in the context of P. falciparum severity/resistance in the Indian population.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
Association of specific TNF and FCGR2A SNPs with cytokine levels and disease severity/resistance was indicated in patients from areas with differential disease endemicity. The data emphasizes the need for addressing the contribution of human genetic factors in malaria in the context of disease epidemiology and population genetic substructure within India.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 448 470 448 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 816 817 816 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 448 469 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
The association of severity of malaria with several human genetic factors is well documented [1] and the disease has been the selective pressure behind several erythrocytic defects such as sickle cell disease, G6PD deficiency and thalassaemia [2,3]. Malaria susceptibility/resistance has been correlated with polymorphisms in more than 30 other genes, some of which have exhibited differential association in distinct populations of the world [1]. Plasmodium falciparum blood infection levels and fever episodes have been linked to chr 5q31-33 [4] and chr10 [5]. While most human gene polymorphism-disease association studies for malaria susceptibility have been carried out on populations from Africa and south-east Asia, there is limited information on malaria-associated gene polymorphisms in Indian populations [6-8].
###end p 11
###begin p 12
###xml 13 27 13 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 172 186 172 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1d</xref>
###xml 13 26 <span type="species:ncbi:5833">P. falciparum</span>
###xml 172 185 <span type="species:ncbi:5833">P. falciparum</span>
###xml 692 697 <span type="species:ncbi:9606">human</span>
###xml 894 902 <span type="species:ncbi:9606">patients</span>
Incidence of P. falciparum malaria in India is high with ~0.9 million cases reported annually in the last few years [9]. Several regions of the country are 'high risk' for P. falciparum with the infection accounting for more than 80% of all malaria cases in certain areas [10,11] (Figure 1d). The population of India represents largely endogamous groups comprising distinct religious communities, castes and isolated tribal populations. The Indian population is genetically heterogeneous as revealed by recent Indian Genome Variation Consortium (IGVC) data on 55 subpopulations of the country [unpublished data]. As differences in genetic structure (population stratification), selection and human adaptation are major confounders in association studies, it is important that case-control association studies for malaria in India be carried out on carefully defined, ethnically-matched sets of patients and controls.
###end p 12
###begin p 13
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 280 282 280 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 287 290 287 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 339 353 339 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 970 983 970 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 339 352 <span type="species:ncbi:5833">P. falciparum</span>
###xml 783 790 <span type="species:ncbi:9606">patient</span>
###xml 937 944 <span type="species:ncbi:9606">patient</span>
###xml 970 983 <span type="species:ncbi:5833">P. falciparum</span>
Gradient maps representing genotype frequency distribution of the minor allele of TNF promoter/enhancer and FCGR2A G/A R131H SNPs across India. A, rs1799964 (-1031T>C); B, rs1800630 (-863C>A); C, rs1801274 (exon4 G>A). Dots on each map depict the 55 IGVC endogamous populations. Ho and FST value of each SNP is indicated. D, map depicting P. falciparum malaria prevalence across the country as percentage of all malaria cases. Areas where incidence is >30% are considered 'high risk'. E, distribution of TNF enhancer haplotypes for the SNPs -1031T>C, -863C>A, -308G>A, -238G>A, -76T>C across Indian populations. The linguistic lineages (TB, Tibeto-Burman; IE, Indo-European; DR, Dravidian; AA, Austro-Asiatic) of populations are indicated. Endogamous populations that contributed to patient and control samples from the endemic and non-endemic region are marked by * and #, respectively in A and E. Blue and green circles in A represent patient recruitment sites in the P. falciparum-endemic and -non-endemic region, respectively.
###end p 13
###begin p 14
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 128 142 128 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 332 346 332 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 722 726 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 128 141 <span type="species:ncbi:5833">P. falciparum</span>
###xml 332 345 <span type="species:ncbi:5833">P. falciparum</span>
Single nucleotide polymorphisms (SNPs) in the 5' regulatory region of TNF and coding region of FCGR2A have been associated with P. falciparum malaria [12-17]. Tumour Necrosis Factor (TNF) is involved in multiple inflammatory and immune responses and plays an important role in the pathogenesis of many infectious diseases including P. falciparum malaria [18]. The transcription of TNF is complex and tightly regulated [19,20]. SNPs in the 5' regulatory region of the gene have been shown to correlate with many infectious and inflammatory diseases [21,22] with conflicting reports regarding their functional significance. SNPs at positions -1031, -857, -376 (rs1800750, G>A), -308 and -238 in the proximal enhancer of the TNF gene exhibit differential associations to malaria and TNF production in different populations [12-14,23-25] suggesting that individual TNF responses may be genetically determined.
###end p 14
###begin p 15
###xml 276 283 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 513 515 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 611 625 607 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 690 692 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 693 695 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 794 796 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 816 818 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 611 624 <span type="species:ncbi:5833">P. falciparum</span>
###xml 660 668 <span type="species:ncbi:9606">children</span>
The human IgG receptor FcgammaRIIa (CD32) is an important link between the cellular and humoral arms of the immune system. It is a low affinity receptor for immunoglobulin subtypes IgG1-4 and also binds C-reactive protein (CRP) with high affinity. A polymorphism in exon 4 of FCGR2A (R131H, G/A) alters its function in vitro; the product of the G allele (131R) has preferential affinity for IgG1 and IgG3 while the A allele (131H) product binds efficiently to IgG2 while retaining its affinity for IgG1 and IgG3 [26]. The high-affinity IgG2 binding 131H allele has been correlated with susceptibility to severe P. falciparum malaria in Africa, particularly in children in Kenya and Gambia [15,16], but failed to show significant independent association with severity of malaria in Thai adults [27]. A recent report [17] has implicated the 131H allele in protection from severe malaria in Sudan.
###end p 15
###begin p 16
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 221 235 221 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 432 446 432 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 221 234 <span type="species:ncbi:5833">P. falciparum</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
###xml 432 445 <span type="species:ncbi:5833">P. falciparum</span>
Screening of the enhancer region of the TNF gene for genetic variants in the ethnically diverse Indian population and correlation of two SNPs (-1031 and -863) with circulating plasma TNF levels in healthy individuals and P. falciparum malaria patients is reported here. Correlation of TNF levels and 5' regulatory region SNPs with severity of disease was investigated in a case-control study with patients and controls drawn from a P. falciparum endemic and a non-endemic region of the country. The FcgammaRIIa R131H polymorphism was also evaluated for correlation with susceptibility to severe malaria in these regions.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Study subjects and sample collection
###end title 18
###begin p 19
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
Analysis of allele frequency distribution of the selected TNF (RefSeq NT_007592.14) and FCGR2A (RefSeq NM_021642) SNPs was carried out in the existing Indian Genome Variation Consortium (IGVC) samples. This validation panel consisted of 1,871 samples drawn from 55 ethnically and linguistically diverse endogamous populations across India [28].
###end p 19
###begin p 20
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 428 442 428 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 380 388 <span type="species:ncbi:9606">patients</span>
###xml 428 441 <span type="species:ncbi:5833">P. falciparum</span>
###xml 717 725 <span type="species:ncbi:9606">patients</span>
###xml 1197 1205 <span type="species:ncbi:9606">patients</span>
###xml 1217 1225 <span type="species:ncbi:9606">patients</span>
###xml 1509 1517 <span type="species:ncbi:9606">patients</span>
###xml 1530 1538 <span type="species:ncbi:9606">patients</span>
For the case-control study for an endemic (Antagarh, Chhattisgarh and Sundargarh, Orissa) and a non-endemic (Lucknow and surrounding areas of Uttar Pradesh) region (Figure 1a), approval was obtained from ethical committees of all participating institutions. Informed consent was obtained from each volunteer/guardian prior to collection. Blood samples (2 to 5 ml) were drawn from patients above five years of age diagnosed with P. falciparum malaria. Diagnosis was carried out by rapid diagnostic test kits (Optimal/Paracheck) followed by confirmation by examination of thick and thin film blood smears. Categorization of severe and non-severe cases was performed according to WHO guidelines [29]. Non-severe malaria patients were blood smear-positive, had fever and lacked symptoms that characterized severe malaria. Severe malaria cases were categorized as cerebral and non-cerebral. Cerebral malaria was characterized by impaired consciousness (coma) with fever. Any one of the following symptoms together with a positive blood smear indicated severe (non-cerebral malaria): severe anaemia, acidotic breathing, pulmonary oedema, hypoglycaemia, increased serum creatinine levels. A total of 121 patients (68 and 53 patients from the endemic and non-endemic region, respectively) and 100 healthy control individuals (42 and 58 uninfected individuals from the endemic and non-endemic region, respectively) were included in the study. Plasma TNF levels in the context of disease severity were analyzed for 175 patients (101 and 74 patients from the endemic and non-endemic region, respectively) and 186 control individuals (98 and 88 individuals from the endemic and non-endemic region, respectively). Control samples were taken from ethnically-matched, unrelated individuals from the endemic region and non-endemic region. Plasma was separated at the time of collection and stored in liquid nitrogen. G6PD level and HbA/S status of each individual was determined.
###end p 20
###begin title 21
Genomic DNA extraction and genotyping
###end title 21
###begin p 22
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 328 335 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 583 587 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 614 621 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 413 420 <span type="species:ncbi:9606">patient</span>
Genomic DNA was extracted from peripheral blood leucocytes using salting-out procedure [30]. For validation of reported SNPs and discovery of novel SNPs, a 511 bp region of the TNF enhancer (-1 to -511) was sequenced in a discovery panel comprising 43 samples from different populations of India [28]. Genotyping of all TNF and FCGR2A SNPs in the IGVC validation panel was done by Sequenom mass spectroscopy. For patient and control samples, genotyping of -1031, -863 and -857 TNF SNPs was done by direct sequencing of a 292 bp PCR product covering nt -782 to -1073. Typing of other TNF SNPs (-308, -238, -76) and FCGR2A G/A (R131H) SNP was done by SNaPShot method (Applied Biosystems). All DNA sequencing and genotyping was performed on 3130xl automated DNA sequencer (Applied Biosystems). Approximately 10% genotypings carried out by SNaPshot were quality checked by DNA sequencing.
###end p 22
###begin title 23
ELISA for TNF
###end title 23
###begin p 24
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
A sandwich ELISA was performed to measure plasma TNF levels using capture monoclonal anti-human TNF antibody (Pierce) and a paired biotinylated anti-human TNF antibody (Pierce). The minimum detection limit of the assay was 2 pg/ml.
###end p 24
###begin title 25
Statistical methods
###end title 25
###begin p 26
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 356 360 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
The chi-square test was performed to evaluate whether the allele frequencies of the populations are in Hardy-Weinberg equilibrium. Comparison of TNF levels among genotypes of the -1031 and -863 SNPs was carried out by non-parametric Kruskal-Wallis test [31]. Pairwise comparison of means for TNF levels was carried out by Mann-Whitney test. Haplotypes for TNF SNPs were generated by PHASE. Linkage disequilibrium (LD) plot for TNF SNPs was generated using Haploview. Odds ratio (OR) for risk assessment was determined using EpiInfotrade mark version 3.4 software with the P-value calculated by Fisher Exact or Mantel-Haenszel test.
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
TNF regulatory region and FCGR2A SNP frequencies vary across Indian populations
###end title 28
###begin p 29
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 969 973 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 1020 1023 1020 1023 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 1044 1045 1044 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 1056 1059 1056 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 1069 1071 1069 1071 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 1131 1135 1131 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 1225 1226 1225 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1238 1239 1238 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1278 1285 1278 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 1422 1424 1422 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 1535 1537 1535 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 750 756 <span type="species:ncbi:9606">humans</span>
Validation of reported TNF 5' regulatory region polymorphisms as well as discovery of possible novel SNPs in TNF promoter/enhancer was carried out by sequencing in representative samples of 43 populations of India (discovery panel) under the Indian Genome Variation Consortium (IGVC) [28]. A novel SNP, -76 T>A (allotted SNP ID: rs41297589), was discovered in the Indian population. Validation of the SNP in the larger panel comprising 1871 samples from 55 populations across India revealed an overall minor allele frequency (MAF) of 0.031. Forty populations, across all linguistic lineages, were polymorphic at this site (Figure 2). This SNP lies within the nt -131 to -63 region of the TNF enhancer that has been reported to be highly conserved in humans and primates [32] and is positioned at the low affinity transcription factor Ets-1 binding site in macrophages and the high affinity NFATp binding site in T and B cells [19]. Of the SNPs analyzed under IGVC, the TNF -76 T>A was among those exhibiting the lowest FST and heterozygosity (Ho) values (FST = 0.017, Ho = 0.052) suggesting negative selection. The distribution of TNF SNPs at positions -1031, -863, -308 and -238 across Indian populations is shown in Figure 1 and Figure 2. The frequency of the A allele of the FCGR2A exon 4 G/A R131H polymorphism across the 55 populations varied from 0.38 to 0.83. The distribution of the AA genotype is shown in Figure 1c. Allele frequency information for these SNPs across all populations may be accessed through the IGVC website [33].
###end p 29
###begin p 30
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
Minor allele frequency (MAF) distribution of TNF SNPs across India. A, rs1799964 (-1031); B, rs1800630 (-863); C, rs1800629 (-308); D, rs361525 (-238); E, rs41297589 (-76).
###end p 30
###begin p 31
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 117 131 117 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 187 200 187 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 966 970 966 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 1012 1019 1012 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 117 130 <span type="species:ncbi:5833">P. falciparum</span>
###xml 149 156 <span type="species:ncbi:9606">Patient</span>
###xml 187 200 <span type="species:ncbi:5833">P. falciparum</span>
###xml 514 522 <span type="species:ncbi:9606">patients</span>
###xml 1347 1354 <span type="species:ncbi:9606">patient</span>
This SNP frequency data was used to plan a case-control study to analyze the association of TNF and FCGR2A SNPs with P. falciparum malaria in India. Patient samples were collected from a P. falciparum-endemic area (Chattisgarh and Orissa) that has perennial and high malaria transmission [11] and a non-endemic region (Uttar Pradesh) with low and seasonal transmission. The main affected populations of the endemic region are isolated tribal groups of the Austro-Asiatic and Dravidian linguistic lineage while the patients in the non-endemic region are primarily from large populations (caste and religious groups) of the Indo-European lineage. Mean MAFs from populations of these regions covered by IGVC were compared (Table 1); allele frequencies of five populations from the non-endemic region (n = 197) and three populations from the endemic region (n = 86) were analyzed. Significant differences between the endemic and non-endemic region were observed for the TNF -1031 and -863 SNPs. The frequency of the FCGR2A (R131H) A allele was also higher in the endemic region although the P value was 0.07. Thus, the healthy control panel constituted for this study comprised ethnically-matched individuals from both regions. The combined control panel comprised equivalent numbers from both these groups and included populations represented in the patient pool.
###end p 31
###begin p 32
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 70 84 70 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 70 83 <span type="species:ncbi:5833">P. falciparum</span>
TNF enhancer and FCGR2A SNP frequencies in IGVdb populations from the P. falciparum endemic and non-endemic regions included in this study.
###end p 32
###begin title 33
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
Homozygotes of TNF -1031C and -863A alleles are associated with elevated circulating TNF levels
###end title 33
###begin p 34
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
The five TNF regulatory region SNPs described above as well as the -857 SNP previously correlated with cerebral malaria [13] were typed in patients and controls. As the -857, -308, -238 and -76 SNPs had relatively low frequency, only the -1031 and -863 SNPs were analyzed further.
###end p 34
###begin p 35
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 11 18 <span type="species:ncbi:9606">patient</span>
###xml 202 210 <span type="species:ncbi:9606">patients</span>
###xml 456 464 <span type="species:ncbi:9606">patients</span>
Within the patient and control groups, significant differences in TNF levels were seen between genotypes of both -1031 and -863 (-1031, P = 0.0178 and 0.0089; -863, P = 0.0481 and 0.023 in controls and patients, respectively)(Table 2). Comparison between homozygotes indicated significant correlation of high TNF levels with the minor allele of both SNPs (P < 0.01) (Table 2). Although heterozygotes had higher levels than major allele homozygotes in both patients and controls, the difference was statistically non-significant.
###end p 35
###begin p 36
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Correlation of TNF levels with genotypes of the -1031 and -863 SNPs in controls and patients. Comparison of means was carried out by Kruskal-Wallis test.
###end p 36
###begin p 37
'n' indicates number of individuals in each category.
###end p 37
###begin p 38
###xml 0 4 0 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a,b </sup>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
a,b TNF levels in TT vs. CC in controls and patients: P < 0.01 (Mann-Whitney test)
###end p 38
###begin p 39
###xml 0 4 0 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c,d </sup>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
c,d TNF levels in CC vs. AA in controls and patients: P < 0.02 (Mann-Whitney test)
###end p 39
###begin p 40
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 245 247 245 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1103 1105 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 128 135 <span type="species:ncbi:9606">patient</span>
###xml 987 994 <span type="species:ncbi:9606">patient</span>
The -1031 and -863 SNPs had a similar distribution pattern in Indian populations (Figure 1, Figure 2). Combined analysis of the patient and control groups indicated that alleles of -1031 and -863 were in linkage disequilibrium (LD) (D' = 0.73, r2 = 0.494) while no linkage was observed with -308 and -238 (Figure 3a). Haplotype analysis of the control groups revealed that the CACGG haplotype (-1031C, -863A, -857C, -308G, -238G) in which both -1031 and -863 were mutated had the highest frequency (0.115) after the major haplotype TCCGG (0.58). The CAGGT haplotype (-1031C, -863A, -308G, -238G, -76T), polymorphic at -1031 and -863, was the predominant haplotype after the major haplotype TCGGT in the IGVdb populations as well (Figure1e). Thus, the possible correlation between TNF levels and the CACGG haplotype was investigated by comparing TNF levels in subjects that were homozygous for the CACGG haplotype and the major haplotype TCCGG. Individuals homozygous for CACGG from both patient and control groups had significantly higher TNF levels than those homozygous for TCCGG (P = 0.0001) (Figure 3b) indicating strong association of the haplotype with elevated TNF levels.
###end p 40
###begin p 41
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 466 474 <span type="species:ncbi:9606">patients</span>
Linkage between TNF regulatory region SNPs and correlation of TNF haplotypes with plasma TNF levels. A, r2 LD plot of four TNF SNPs (-1031, -863, -308, -238). Value in each cell is the percent D' between SNP pairs. B, Correlation of TNF promoter haplotype (-1031C, -863A, -857C, -308G, -238G) with elevated TNF levels compared to the major haplotype TCCGG. Mean plasma TNF levels were compared using Mann-Whitney test (z = -3.73, P = 0.0002). C, Plasma TNF level in patients and controls. Pairwise comparison of means by non-parametric Mann-Whitney test: severe versus control, z = 4.41, P < 0.0001; non-severe versus control, z = 0.67, P = 0.25; severe versus non-severe, z = 3.13, P = 0.0009.
###end p 41
###begin title 42
###xml 38 52 38 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 38 51 <span type="species:ncbi:5833">P. falciparum</span>
High TNF levels correlate with severe P. falciparum malaria
###end title 42
###begin p 43
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 582 596 582 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">children</span>
###xml 443 451 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 582 595 <span type="species:ncbi:5833">P. falciparum</span>
###xml 653 661 <span type="species:ncbi:9606">patients</span>
###xml 760 768 <span type="species:ncbi:9606">patients</span>
###xml 901 909 <span type="species:ncbi:9606">patients</span>
Elevated TNF levels in malaria patients have been correlated with severe disease manifestation in other world populations [34,35] although significant differences between plasma TNF levels were not observed between uncomplicated, severe anemia, and cerebral malaria patients in a recent report on Malian children [23] suggesting the possibility of population-specific differences. An earlier study from India [36] reported higher TNF level in patients with multiple organ dysfunction and those who died. Our results indicated significantly higher TNF levels in patients with severe P. falciparum malaria when compared with controls (P < 0.0001) or with patients with non-severe malaria (P = 0.0009) (Figure 3c). The difference in TNF levels between non-severe patients and controls was not significant (P = 0.25). Significant differences were not seen between non-cerebral severe and cerebral malaria patients (P = 0.102) suggesting correlation with severe disease manifestation including cerebral malaria.
###end p 43
###begin title 44
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 65 79 65 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 65 78 <span type="species:ncbi:5833">P. falciparum</span>
Correlation of TNF and FCGR2A SNPs with susceptibility to severe P. falciparum malaria
###end title 44
###begin p 45
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1242 1246 1242 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 467 474 <span type="species:ncbi:9606">patient</span>
The -1031C allele was associated with disease severity with higher percentage of the mutant genotypes observed in severe patients compared with controls (55.5% versus 42%, OR = 1.76, 95% CI = 0.97-3.2, P = 0.048) (Table 3). A similar trend was observed for the -863A allele (51.7% versus 39%, OR = 1.69, 95% CI = 0.93-3.09, P = 0.065). Significant difference in distribution of the minor allele for both -1031 and -863 was also observed between severe and non-severe patient groups (-1031, 55.6% versus 40.4%, OR = 1.87, 95% CI = 1.03-3.4, P = 0.028; -863, 51.85% versus 36.8%, OR = 1.84, 95% CI = 1.01-3.38, P = 0.033) indicating association of the minor allele with disease severity. Interestingly, when severe cases were analyzed separately as non-cerebral severe (NCM, n = 33) and cerebral malaria (CM, n = 21), stronger association of the -1031C allele was indicated with non-cerebral severe malaria as compared to cerebral malaria (CM versus non-severe, OR = 1.38, 95% CI = 0.76-2.52, P = 0.25; NCM versus non-severe, OR = 2.25, 95% CI = 1.23-4.13, P = 0.004) suggesting association of the minor allele with non-cerebral but not cerebral severe disease manifestation. Taken together, our data indicated a strong correlation between the TNF -1031 and -863 SNPs and cytokine levels in individuals, association of high TNF level with severe malaria as well as correlation of -1031C and -863A polymorphisms with disease severity.
###end p 45
###begin p 46
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Genotype distribution of TNF regulatory region SNPs in controls and patients.
###end p 46
###begin p 47
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 95 109 95 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 720 721 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1850 1864 1850 1864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1975 1989 1971 1985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 95 108 <span type="species:ncbi:5833">P. falciparum</span>
###xml 175 182 <span type="species:ncbi:9606">patient</span>
###xml 1174 1181 <span type="species:ncbi:9606">patient</span>
###xml 1850 1863 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1975 1988 <span type="species:ncbi:5833">P. falciparum</span>
In light of the differential association reported for the FCGR2A G/A (R131H) polymorphism with P. falciparum malaria in different populations, we analyzed its distribution in patient and control groups. Combined analysis of endemic and non-endemic region samples indicated that the high affinity IgG2-binding 131H allele associates with protection from disease manifestation; the GG homozygote for 131R correlated with susceptibility to severe malaria (severe vs. control, OR for GG and AA = 3.9, P = 0.026) (Figure 4). Heterozygote for the G allele also correlated with manifestation of disease (severe vs. control, OR for GA and AA = 2.56, P = 0.013; non-severe vs. control, OR for GA and AA = 2.73, P = 0.01) (Figure 4). No significant difference was observed in the distribution of GA and GG genotypes in different disease groups (P > 0.05 in all odds ratio calculations). The 131H/H genotype was associated with protection with the control group having a significantly higher proportion of the AA genotype compared to the non-severe (41.3% versus 20.3%, OR = 2.78, 95% CI = 1.41-5.5, P = 0.001) and severe (41.3% versus 20.6%, OR = 2.61, 95% CI = 1.34-5.13, P = 0.002) patient groups. After stratifying for populations in the endemic and non-endemic region, a stronger association of the G allele with severe malaria was observed in the non-endemic region (severe vs. control, OR for GG and AA = 4.67, 95% CI = 0.75-33.94, P = 0.047 in non-endemic region and OR for GG and AA = 2.83, 95% CI = 0.17-33.76, P = 0.32 in endemic region; severe vs. control, OR for GA and AA = 2.59, 95% CI = 0.93-7.4, P = 0.043 in non-endemic region and OR for GA and AA = 2.43, 95% CI = 0.5-12.06, P = 0.178 in endemic region). Our results indicate that the 131R allele is associated with susceptibility to disease with the 131H/H genotype being protective against P. falciparum malaria and suggest differences in FcgammaRIIa R131H allelic association profiles in regions with differential P. falciparum prevalence and transmission.
###end p 47
###begin p 48
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 50 64 50 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 50 63 <span type="species:ncbi:5833">P. falciparum</span>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
Correlation of FCGR2A G/A R131H polymorphism with P. falciparum malaria in combined analysis of samples from the endemic and non-endemic region. Genotype frequency distribution in controls and patients is depicted. Odds ratios (OR) indicate association of the G allele with increased risk of malaria.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 23 37 23 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 697 701 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 973 987 973 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1488 1490 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 23 36 <span type="species:ncbi:5833">P. falciparum</span>
###xml 398 402 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 973 986 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1566 1574 <span type="species:ncbi:9606">patients</span>
The role of TNF during P. falciparum malaria infection has been described as both protective and pathogenic [37,38]. At low levels, TNF is believed to augment parasite killing by macrophage activation and subsequent release of cytokines, whereas high TNF level has been associated with severe manifestations like acute respiratory distress and cerebral malaria. A recent study on lethal malaria in mice has implicated high levels of TNF in impairment of dendritic cell function thus contributing to immunosuppression associated with malaria [39]. Individual variation in TNF production mainly by macrophages and NK cells is likely to influence severe disease manifestation. Although the effect of TNF enhancer SNPs on transcription levels of the cytokine remains controversial [40,41], several studies have implicated their role in determining TNF levels in individuals and consequently influencing their response to a gamut of autoimmune and infectious diseases including P. falciparum malaria [42,43]. While association of the -863A substitution with reduced TNF levels was described in the Swedish population [44], a study from Japan [45] reported association of the -1031, -863 and -857 polymorphisms with increased reporter gene expression and increased concanavalin A-stimulated TNF production from peripheral blood mononuclear cells. Additionally, the ubiquitous transcription factor OCT-1 has been reported to exhibit allele-specific binding to the variant allele -863A or -857T [46]. In our study as well, higher circulating TNF levels in both controls and patients were associated with the -1031C and -863A polymorphisms. The two SNPs were in LD and the CACGG haplotype (-1031C, -863A, -857C, -308G, -238G) was strongly associated with higher plasma TNF levels. This haplotype had the highest estimated frequency in controls (0.115) after the major haplotype TCCGG (0.58). As the -1031 and -863 polymorphisms are present in high frequency in India and the CAGGT haplotype (-1031C, -863A, -308G, -238G, -76T) is also the predominant haplotype after the major haplotype TCGGT in most of the 55 IGVdb populations analyzed by us, the two SNPs may play a significant role in modulating the immune response and influencing the outcome of several infectious diseases.
###end p 50
###begin p 51
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
Our results indicated association of the -1031 and -863 TNF SNPs with increased risk of severe malaria. A recent study on Thailand/Myanmar border populations reported association of the TNF -1031C, -863C, -857C allele with severe malaria [14]. This allele was not in significant LD with HLA-DRB1 and HLA-B alleles indicating that association with susceptibility to cerebral malaria was not because of LD with the HLA alleles. To our knowledge, our study is the first report of independent association of the -863 polymorphism with increased risk of severe disease.
###end p 51
###begin p 52
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 118 132 118 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 768 770 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 771 773 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 998 1000 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1001 1003 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1095 1109 1091 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1134 1136 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1280 1282 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1809 1822 1801 1814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 1884 1886 1876 1878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 2047 2049 2031 2033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 118 131 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1095 1108 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1809 1822 <span type="species:ncbi:5833">P. falciparum</span>
In contrast to previous reports [15,16,27], our data implicates the low-IgG2 binding 131R allele in susceptibility to P. falciparum malaria with the high-affinity IgG2 binding 131H/H genotype being associated with protection from disease. Our results are in agreement with a recent study on subjects from Sudan that demonstrated that the 131R/R genotype and the 131R allele were significantly associated with the odds of severe malarial disease [17]. The 131H/H genotype was associated with a reduced risk of both non-severe and severe malaria in our study, indicating a role for the polymorphism in protection from clinical manifestation of disease. The FcgammaRIIa 131H receptor binds IgG3 more efficiently than 131R and is the only high-affinity receptor for IgG2 [47,48]. Cytophilic antibodies are thought to be critical in protective immunity and several studies have shown an association between increased levels of IgG1 and IgG3 subclasses and protection from malarial infection or disease [49-51]. High levels of IgG2 antibodies to MSP-2 and RESA have been associated with resistance to P. falciparum malaria in Burkina Faso [52]. IgG2 antibodies may be cytophilic in individuals carrying the 131H allele as these bind Fcgamma receptor with greater affinity. Nasr et al. [17] showed that IgG3 antibodies specific to crude malarial antigen were more associated with reduced risk of clinical malaria in 131H/H individuals than in 131R/R individuals; weak but statistically significant association between low levels of anti-malarial IgG2 antibodies specific to a recombinant antigen in 131H allele carriers and reduced risk of severe malaria was also found. Our results also suggest a role for the 131H/H genotype in protection against clinical malaria. This may be mediated by enhanced phagocytosis of P. falciparum-infected erythrocytes by cells expressing the 131H receptor [53] or by FcgammaRIIa and FcgammaRIII-dependent parasite neutralizing activity of monocytes during antibody-dependent cell-mediated inhibition of parasite growth [54].
###end p 52
###begin p 53
###xml 455 469 451 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 513 515 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 628 630 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 691 705 687 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 754 768 750 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 795 797 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1d</xref>
###xml 859 861 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 1085 1099 1077 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 455 468 <span type="species:ncbi:5833">P. falciparum</span>
###xml 691 704 <span type="species:ncbi:5833">P. falciparum</span>
###xml 754 767 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1085 1098 <span type="species:ncbi:5833">P. falciparum</span>
A difference in the degree of association of the FcgammaRIIa 131R allele with severe malaria observed in the two regions included in our study may be a reflection of the nature of immune response against malaria in areas characterized by low and seasonal transmission or endemic areas with high transmission rates. Although a more detailed analysis of this is warranted, it may be relevant that association of high IgG2 levels with protection from severe P. falciparum malaria observed in the Burkina Faso study [52] as well as the association of the low IgG2 binding 131R allele with disease severity in a Sudanese population [17] were both carried out from areas characterized by seasonal P. falciparum malaria transmission. As evident from the map of P. falciparum incidence in India (Figure 1d) and the distribution of the FcgammaRIIa AA genotype (Figure 1c), higher frequency of the protective 131H/H genotype was observed in 'high risk' and endemic areas of east and north-east India. This is suggestive of possible selection of the protective A allele in populations exposed to P. falciparum malaria in these regions.
###end p 53
###begin title 54
Conclusion
###end title 54
###begin p 55
###xml 40 54 40 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 362 369 362 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 457 464 457 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCGR2A </italic>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 895 909 891 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1017 1031 1009 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 40 53 <span type="species:ncbi:5833">P. falciparum</span>
###xml 539 547 <span type="species:ncbi:9606">patients</span>
###xml 895 908 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1017 1030 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1124 1129 <span type="species:ncbi:9606">human</span>
In light of the increasing incidence of P. falciparum malaria and its concentration in specific regions of India, we initiated a case-control study to understand the role of genetic variants of specific immune regulatory molecules in malaria severity/resistance in an endemic and non-endemic region of the country. Differences in frequencies of TNF enhancer and FCGR2A SNPs were observed in populations from the two regions. Association of specific TNF and FCGR2A SNPs with cytokine levels and disease severity/resistance was indicated in patients. The TNF enhancer haplotype carrying the -1031 and -863 SNPs is the predominant haplotype after the major haplotype in most Indian populations and correlated with enhanced TNF levels. In addition, the FcgammaRIIa 131R low affinity IgG2-binding allele was associated with susceptibility to disease with the 131H/H genotype being protective against P. falciparum malaria. Differences in FcgammaRIIa allelic association profiles were observed in regions with differential P. falciparum prevalence and transmission. The data underlines the need for addressing the contribution of human genetic factors in malaria in the context of disease epidemiology and population genetic substructure within India.
###end p 55
###begin title 56
Abbreviations
###end title 56
###begin p 57
TNF, tumour necrosis factor; FcgammaRIIa, Fc gamma receptor IIa; SNP, single nucleotide polymorphism; MAF, minor allele frequency; ELISA, enzyme-linked immunosorbent assay.
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
###xml 452 460 <span type="species:ncbi:9606">patients</span>
SH and VV conceived and designed the study and contributed to execution of research. SH and S Sinha wrote the manuscript. S Sinha, SKM, and S Sharma carried out genotyping, ELISAs, and data analysis and contributed to sample collection and processing. PKP, PKM, SKS, RMB, HJ and APD helped in design and implementation of field studies. SM, SSP, SKM, BKR, RCA and SA are clinicians who contributed to diagnosis and categorization of falciparum malaria patients. The Indian Genome Variation Consortium (IGVC) comprises scientists from six institutes of the Council for Scientific and Industrial Research with Dr. S.K. Brahmachari, Institute of Genomics and Integrative Biology, New Delhi as coordinator. Collection of endogamous population samples across India and Sequenom genotyping data analyzed here was coordinated under IGVC. SH is a member of the consortium. All authors have read and approved the final manuscript.
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
We are grateful to all donors and their families. We thank Dr. Debasis Das for help with gradient maps, Dr. Prashant, Dr. Prerna, Dr. G.N. Jha and Subir Biswas for help with sample collection and the UP State Department for Malaria and Vector Borne Diseases for support. This work was supported by grants to SH from the Council of Scientific and Industrial Research (CSIR) (CMM0016) and to SH and VV from the Department of Biotechnology, Government of India (BT/PR6065/MED/14/738/2005). This is CDRI communication number 7319.
###end p 61
###begin article-title 62
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
How malaria has affected the human genome and what human genetics can teach us about malaria
###end article-title 62
###begin article-title 63
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PD</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance
###end article-title 63
###begin article-title 64
###xml 84 106 80 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 84 105 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Both heterozygous and homozygous alpha-thalassemia protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya
###end article-title 64
###begin article-title 65
###xml 26 48 26 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 26 47 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region
###end article-title 65
###begin article-title 66
Genome-wide linkage analysis of malaria infection intensity and mild disease
###end article-title 66
###begin article-title 67
DNA sequence variation and haplotype structure of the ICAM1 and TNF genes in 12 ethnic groups of India reveal patterns of importance in designing association studies
###end article-title 67
###begin article-title 68
Molecular basis of G6PD deficiency in India
###end article-title 68
###begin article-title 69
Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-eastern India?
###end article-title 69
###begin article-title 70
National Vector Borne Disease Control Programme
###end article-title 70
###begin article-title 71
Forest malaria in Chhindwara, Madhya pradesh, central India: a case study in a tribal community
###end article-title 71
###begin article-title 72
Epidemiology of malaria transmission and development of natural immunity in a malaria-endemic village, San Dulakudar, in Orissa state, India
###end article-title 72
###begin article-title 73
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
###end article-title 73
###begin article-title 74
Strong association of a tumor necrosis factor-alpha promoter allele with cerebral malaria in Myanmar
###end article-title 74
###begin article-title 75
###xml 43 46 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF</italic>
Significant association between TNF-alpha (TNF) promoter allele (-1031C, -863C, and -857C) and cerebral malaria in Thailand
###end article-title 75
###begin article-title 76
###xml 99 121 99 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 70 77 <span type="species:ncbi:9606">infants</span>
###xml 99 120 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Fcg Receptor IIa (CD32) Polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay cohort project
###end article-title 76
###begin article-title 77
Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa
###end article-title 77
###begin article-title 78
###xml 100 122 100 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 100 121 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 142 150 <span type="species:ncbi:9606">patients</span>
Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients
###end article-title 78
###begin article-title 79
The pathogenic basis of malaria
###end article-title 79
###begin article-title 80
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 62 65 <span type="species:ncbi:9860">Elk</span>
A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the Tumor Necrosis Factor Alpha promoter in vivo
###end article-title 80
###begin article-title 81
Inducer-specific enhanceosome formation controls Tumor Necrosis Factor Alpha gene expression in T lymphocytes
###end article-title 81
###begin article-title 82
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kappaB transcription factors
###end article-title 82
###begin article-title 83
The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population
###end article-title 83
###begin article-title 84
###xml 131 153 131 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 117 125 <span type="species:ncbi:9606">children</span>
###xml 131 152 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Alleles 308A and 238A in the Tumor Necrosis Factor Alpha gene promoter do not increase the risk of severe malaria in children with Plasmodium falciparum infection in Mali
###end article-title 84
###begin article-title 85
Severe malarial anemia and cerebral malaria are associated with different Tumor Necrosis Factor Promoter alleles
###end article-title 85
###begin article-title 86
###xml 88 94 <span type="species:ncbi:9606">infant</span>
Tumor Necrosis Factor-a Promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in Western Kenya: Asembo Bay cohort project IX
###end article-title 86
###begin article-title 87
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
A single amino acid in the second Ig-like domain of the human Fcy receptor II is critical for human IgG2 binding
###end article-title 87
###begin article-title 88
Fcgamma receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria
###end article-title 88
###begin article-title 89
The Indian Genome Variation database (IGVdb): a project overview
###end article-title 89
###begin article-title 90
Severe falciparum malaria
###end article-title 90
###begin article-title 91
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 91
###begin article-title 92
Vassar Stats
###end article-title 92
###begin article-title 93
Identification of phylogenetic footprints in primate tumor necrosis factor-alpha promoters
###end article-title 93
###begin article-title 94
Indian Genome Variation Database
###end article-title 94
###begin article-title 95
Malarial toxins and the regulation of parasite density
###end article-title 95
###begin article-title 96
Pathogenesis of malaria and clinically similar conditions
###end article-title 96
###begin article-title 97
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Plasma glucose and tumor necrosis factor-alpha in adult patients with severe falciparum malaria
###end article-title 97
###begin article-title 98
###xml 45 66 45 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 45 66 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Cellular basis of early cytokine response to Plasmodium falciparum
###end article-title 98
###begin article-title 99
Tumor necrosis factor-alpha in the pathogenesis of cerebral malaria
###end article-title 99
###begin article-title 100
Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell function
###end article-title 100
###begin article-title 101
Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease
###end article-title 101
###begin article-title 102
###xml 145 153 <span type="species:ncbi:9606">patients</span>
Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals
###end article-title 102
###begin article-title 103
Polymorphism in Tumor Necrosis Factor genes associated with mucocutaneous leishmaniasis
###end article-title 103
###begin article-title 104
Association of TNF-alpha/LTA polymorphisms with Crohn's disease in Koreans
###end article-title 104
###begin article-title 105
A common functional polymorphism in the promoter region of tumor necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha
###end article-title 105
###begin article-title 106
###xml 46 51 <span type="species:ncbi:9606">human</span>
Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese
###end article-title 106
###begin article-title 107
Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter
###end article-title 107
###begin article-title 108
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2
###end article-title 108
###begin article-title 109
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 123 128 <span type="species:ncbi:9606">human</span>
Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function
###end article-title 109
###begin article-title 110
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity
###end article-title 110
###begin article-title 111
###xml 90 111 90 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 90 111 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: Functional role of IgG subclasses
###end article-title 111
###begin article-title 112
###xml 66 87 66 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 66 87 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The IgG-subclass distribution of naturally acquired antibodies to Plasmodium falciparum, in relation to malaria exposure and severity
###end article-title 112
###begin article-title 113
###xml 90 112 90 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 90 111 <span type="species:ncbi:5833">Plasmodium falciparum</span>
High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria
###end article-title 113
###begin article-title 114
###xml 43 64 43 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 43 64 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Fc gamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro
###end article-title 114
###begin article-title 115
A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of FcgammaRII and FcgammaRIII
###end article-title 115

